home / stock / glpg / glpg quote
Last: | $24.89 |
---|---|
Change Percent: | 0.0% |
Open: | $25.39 |
Close: | $24.89 |
High: | $25.475 |
Low: | $24.86 |
Volume: | 65,908 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$24.89 | $25.39 | $24.89 | $25.475 | $24.86 | 65,908 | 07-04-2024 |
$24.89 | $25.39 | $24.89 | $25.475 | $24.86 | 65,908 | 07-03-2024 |
$25.34 | $25.13 | $25.34 | $25.415 | $25.02 | 101,134 | 07-02-2024 |
$25.01 | $24.78 | $25.01 | $25.46 | $24.78 | 179,870 | 07-01-2024 |
$24.78 | $25.06 | $24.78 | $25.08 | $24.78 | 240,016 | 06-28-2024 |
$25.14 | $24.99 | $25.14 | $25.31 | $24.84 | 197,460 | 06-27-2024 |
$25.14 | $25.29 | $25.14 | $25.3123 | $25.02 | 128,994 | 06-26-2024 |
$25.63 | $25.87 | $25.63 | $25.91 | $25.61 | 72,882 | 06-25-2024 |
$26.18 | $25.98 | $26.18 | $26.19 | $25.89 | 130,131 | 06-24-2024 |
$25.75 | $25.64 | $25.75 | $25.85 | $25.53 | 95,615 | 06-21-2024 |
$25.63 | $25.77 | $25.63 | $25.79 | $25.61 | 65,159 | 06-20-2024 |
$25.84 | $26.02 | $25.84 | $26.02 | $25.74 | 107,768 | 06-19-2024 |
$25.84 | $26.02 | $25.84 | $26.02 | $25.74 | 107,768 | 06-18-2024 |
$25.74 | $25.88 | $25.74 | $25.88 | $25.32 | 123,384 | 06-17-2024 |
$25.44 | $25.37 | $25.44 | $25.6125 | $25.315 | 132,414 | 06-14-2024 |
$25.72 | $26 | $25.72 | $26.01 | $25.64 | 124,652 | 06-13-2024 |
$26.05 | $26.07 | $26.05 | $26.43 | $26.02 | 192,242 | 06-12-2024 |
$26.2 | $26.12 | $26.2 | $26.28 | $26.07 | 80,439 | 06-11-2024 |
$26.41 | $26.42 | $26.41 | $26.42 | $26.23 | 111,679 | 06-10-2024 |
$26.76 | $26.87 | $26.76 | $27 | $26.74 | 85,738 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell therapy) produced on Galapagos' decentralized manufacturing platform in patients with head & neck cancer Uza-cel has shown encouraging resul...
2024-05-11 10:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...